newsfilter
← Latest News
GlobeNewswire·

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing precision treatments for